Beruflich Dokumente
Kultur Dokumente
Recent advances
in cataract and
refractive surgery
by Dr.
b
D PONG Chiu
Chi F
Fai,
i J
Jeffrey
ff
Encephalitis and
Meningococcus
Vaccine
by Dr. CHAN Yee Shing, Alvin
Contents
Editorial 1
Spotlight 1 2
Encephalitis and Meningococcus
Vaccine
Spotlight 2 9
Recent advances in cataract
and refractive surgery
Cardiology 14
A lady presented with pulseless electrical
activity
Dermatology 16
A lady with itchy skin for three years
Spotlight 1
Encephalitis and
Meningococcus
Vaccine
Spotlight 2
Recent advances in
cataract and refractive
surgery
2015 12 15
2865 0943
;
www.hkmacme.org
EDITORIAL
Chief Editor
Dr. WONG Bun Lap, Bernard
Executive Committee
Dr. CHAN Yee Shing, Alvin
Dr. CHENG Chi Man
Dr. CHEUNG Hon Ming
Dr. CHOI Kin
Dr. CHOW Pak Chin, JP
Dr. HO Chung Ping, MH, JP
Dr. HO Hung Kwong, Duncan
Dr. LAM Tzit Yuen, David
Dr. LI Sum Wo, MH
Dr. SHIH Tai Cho, Louis
Dr. TSE Hung Hing, JP
Dr. WONG Bun Lap, Bernard
Cardiology
Dr. CHEN Wai Hong
Dr. HO Hung Kwong, Duncan
Dr. LEE Pui Yin
Dr. LI Siu Lung, Steven
Dr. WONG Bun Lap, Bernard
Dr. WONG Shou Pang, Alexander
Dr. WONG Wai Lun, Warren
Neurosurgery
Dr. CHAN Ping Hon, Johnny
Colorectal Surgery
Dr. CHAN Cheung Wah
Dr. LEE Yee Man
Dr. TSE Tak Yin, Cyrus
Dermatology
Dr. CHAN Hau Ngai, Kingsley
Dr. HAU Kwun Cheung
Dr. SHIH Tai Cho, Louis
Endocrinology
Dr. LEE Ka Kui
Dr. LO Kwok Wing, Matthew
Paediatrics
Dr. CHAN Yee Shing, Alvin
Dr. FUNG Yee Leung, Wilson
Dr. TSE Hung Hing, JP
Dr. YEUNG Chiu Fat, Henry
Plastic Surgeon
Dr. NG Wai Man, Raymond
ENT
Dr. CHOW Chun Kuen
Psychiatry
Dr. LAI Tai Sum, Tony
Dr. LEUNG Wai Ching
Dr. WONG Yee Him, John
Radiology
Dr. CHAN Ka Fat, John
Dr. CHAN Yip Fai, Ivan
Respiratory Medicine
Dr. LEUNG Chi Chiu
Dr. WONG Ka Chun
Dr. YUNG Wai Ming, Miranda
Rheumatology
Dr. CHAN Tak Hin
Dr. CHEUNG Tak Cheong
Urology
Dr. CHEUNG Man Chiu
Dr. KWOK Ka Ki
Dr. KWOK Tin Fook
Vascular Surgery
Dr. TSE Cheuk Wa, Chad
Dr. YIEN Ling Chu, Reny
HKMA Secretariat
Ms. Jovi LAM
Miss Sophia LAU
Miss Irene GOT
General Practice
Dr. YAM Chun Yin
General Surgery
Dr. LAM Tzit Yuen, David
Dr. Hon. LEUNG Ka Lau
Geriatric Medicine
Dr. KONG Ming Hei, Bernard
Dr. SHEA Tat Ming, Paul
Haematology
Dr. AU Wing Yan
Dr. MAK Yiu Kwong, Vincent
Hepatobiliary Surgery
Dr. CHIK Hsia Ying, Barbara
Dr. LIU Chi Leung
Medical Oncology
Dr. TSANG Wing Hang, Janice
Nephrology
Dr. CHAN Man Kam
Dr. HO Chung Ping, MH, JP
Dr. HO Kai Leung, Kelvin
Ophthalmology
Dr. CHOW Pak Chin, JP
Dr. LIANG Chan Chung, Benedict
Dr. PONG Chiu Fai, Jeffrey
Gastroenterologist
Dr. NG Fook Hong
Neurology
Dr. FONG Chung Yan, Gardian
Dr. TSANG Kin Lun, Alan
Cardiothoracic Surgery
Dr. CHENG Lik Cheung
Dr. CHIU Shui Wah, Clement
Dr. CHUI Wing Hung
Dr. LEUNG Siu Man, John
Family Medicine
Dr. LAM King Hei, Stanley
Dr. LI Kwok Tung, Donald, SBS, JP
NOTICE
Medical knowledge is constantly changing. Standard safety precautions must be followed, but as new research
and clinical experience broaden our knowledge, changes in treatment and drug therapy may become necessary
or appropriate. Readers are advised to check the most current product information provided by the manufacturer
of each drug to be administered to verify the recommended dose, the method and duration of administration, and
contraindications. It is the responsibility of the practitioner, relying on experience and knowledge of the patient, to
determine dosages and best treatment for each individual patient. Neither the Publisher nor the Authors assume any
liability for any injury and/or damage to persons or property arising from this publication.
Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does
not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its
manufacturer.
SPOTlight -1
Encephalitis and
Meningococcus
Vaccine
INTRODUCTION
VIRAL
AMPLIFICATION
3
JAPANESE ENCEPHALITIS
Japanese encephalitis is caused by a virus, called the
Japanese Encephalitis Virus (JEV). It is the leading cause
of vaccine-preventable encephalitis in Asia and the
Western Pacific. JEV is maintained in an enzootic cycle
involving mosquitoes and amplifying vertebrate hosts,
mainly pigs and wild birds. The virus is transmitted to
humans primarily by Culicine mosquitoes, viz Culex
Tritaeniorhynchus which breed in flooded rice fields and
pools of stagnant water and most often feed outdoors
Infected
mosquitoes
transmit virus
to humans
Infected mosquitoes
reintroduce virus to
vertebrates
CLINICAL MANIFESTATION
Patients with Japanese encephalitis have a history
of mosquito exposure in an endemic area, with an
incubation period of 4-14 days. Most cases are
asymptomatic, subclinical or mild, presenting with
vague headache, diarrhoea, nausea, myalgia and
fever. Only 1 per 250 Japanese encephalitis virus (JEV)
infections results in symptomatic disease. In the severe
cases, symptoms could rapidly progress from ataxia,
weakness, and movement disorders to acute severe
headache, high fever, meningismus, delirium and
coma. Convulsions develop in 66% of infected persons,
most often children. Mutism has been reported as a
presenting symptoms. A syndrome of acute flaccid
paralysis has been described. Generalized weakness,
hypertonia and hyperreflexia are common. Papilledema
occurs, albeit in less than 10% of patients. Cranial
nerve findings (e.g. disconjugate gaze, cranial nerve
palsies) are found in 33% of patients. Fever disappears
by the second week, and extrapyramidal symptoms
develop as the other neurological symptoms disappear.
Extrapyramidal signs are common, including mask-like
faces, tremors, rigidity and choreoathetoid movements.
www.hkmacme.org
SPOTlight -1
INVESTIGATIONS
Laboratory findings are mostly non-specific. 15% of
pediatric cases showed thrombocypenia. Inappropriate
Antidiuretic hormone secretions may occur with
hyponatremia. Viral isolation with JEV found in clinical
specimens, or even the identification of positive genetic
viral sequences in tissues, blood or cerebrospinal fluid
(CSF), is diagnostic. Immunoassay of immunoglobulin M
capture enzyme-linked immunoassay (ELISA) of serum
or CSF is the standard diagnostic test for Japanese
encephalitis.
MRI findings often show bilateral thalamic lesions with
hemorrhage. Hyper-intense lesions may be observed
in the thalamus, cerebrum or cerebellum in the T2weighted MRI scans. EEG often reveals diffuse slowing,
a diffuse delta pattern with spikes, theta waves and
burst suppression.
MANAGEMENT
No clearly effective antiviral agents exist for JEV. The
mainstay of management is supportive, often requiring
www.hkmacme.org
JAPANESE ENCEPHALITIS
VACCINATION
In comparison to another notorious deadly vector-borne
viral disease, dengue fever, vaccines are available for JE.
In the past, Hong Kong had very limited supply of the old
JEV vaccine, which was also notorious for its many side
effects. The demand for vaccination was really small.
Now it is different.
Firstly, many Chinese residents would come to Hong
Kong to be vaccinated for themselves and their children,
as they have confidence in our system. Japanese
encephalitis is endemic in many parts of China. Those
living in the northern part of the New Territories might
be worried especially if living near the pig farms
and trenches with stagnant water that breed Culex
Tritaenorhynchus which harbours JEV in Hong Kong.
Thirdly, JEV vaccine is indicated for people travelling
to regions which are endemic with JEV, for students
going to other regions for exchange and international
studies, for those living near pig farms or in mainland
for a month or more, and for those worried about Culex
Tritaenorhynchus which exists in many different districts
in Hong Kong.
In fact, JEV immunization is recommended for children
from infancy onward in regions like northern Australia,
China, Japan, Korea, Malaysia, Taiwan and Thailand.
SPOTlight -1
MENINGOCOCCAL MENINGITIS
I asked Jenny what she would do after the project. She
said she would then go to USA for university education
in California. She would be required to have certain
vaccines before going to the States. Jenny would most
likely have received most vaccines in the past except the
meningococcal vaccine.
In the past, when Jenny was a child, few would have
meningococcal vaccine in Hong Kong as it was not
commonly available in clinics. Though still not in the
standard childhood immunization scheme, it is now
readily available in private clinics.
Meningococcal A, C, Y and W-135 polysaccharide
vaccine is indicated for active immunization to prevent
invasive meningococcal disease caused by Neisseria
meningitides serogroups A, C, Y and W-135. A
commonly used form could safely be given to children
aged 2 years or older. In America it is now advised
CLINICAL FEATURES
Meningococcal meningitis has an acute onset of high
fever, intense headache, nausea, vomiting, photophobia
and meningismus. Lethargy or drowsiness would often
progress to stupor. If coma is present, the prognosis
would be poor. Some patients have rash, which usually
points to disease progression.
A more serious form of meningococcal disease,
though less common, is meningococcal septicemia,
characterized by a hemorrhagic rash, and a rapid
circulatory collapse. If there are large petechial
hemorrhages in skin and mucosal membranes, fever,
septic shock as well as Disseminated Intravascular
Coagulation (DIC), it is called Waterhouse-Friderichsen
syndrome, and the prognosis is poor.
Sometimes, subacute infection with slower progression
in several days, could present in infants or young kids,
with irritability, projectile vomiting, focal or secondarily
generalized convulsions, and a bulging anterior
fontanelle if it is not yet closed. In children, the classical
signs and symptoms could be absent even when fever
and status epilepticus exist. We need to be very alert
with an index of suspicion always in mind not to miss the
diagnosis in time.
www.hkmacme.org
SPOTlight -1
DIAGNOSIS
Laboratory findings of the CSF confirm the diagnosis,
with increased opening pressure (180 mm water),
neutrophilic pleocytosis (WBC counts 10-10,000/uL
mostly neutrophils), low CSF glucose (<45 mg/dL), high
CSF protein (>45 mg/dL).
Haemophilus
influenzae b
Meningococcus
Pneumococcus
Available vaccines
MANAGEMENT
Initial empiric therapy, until the etiology of the meningitis
is elucidated, should include dexamethasone, a
third generation cephalosporin, e.g. ceftriaxone
or cefotaxime, vancomycin, and acyclovir if initial
CSF showed lymphoctosis rather than neutrophilia.
Ceftriaxone or cefotaxime will be the drug of choice for
the treatment of meningococcal meningitis after the
diagnosis is confirmed.
As the disease is so serious with significant mortality rate
and morbidity, it is always important to prevent it. There are
effective vaccines to prevent meningococcal meningitis.
THE CONSEQUENCES OF
MENINGOCOCCAL DISEASES
According to World Health Organization (WHO), the
mortality rate of meningococcal meningitis is up to 10%.
About 20% of patients surviving meningococcal
meningitis suffer from sequelae such as:
Mental retardation
Hearing loss
Neurologic disability
Epilepsy
Gangrene extremities due to ischemia
www.hkmacme.org
Haemophilus
influenzae b
(Hib) conjugate
vaccine or
Hib-containing
vaccine
4-valent
(A, C, W-135
and Y)
Meningococcal
conjugate
vaccine
Pneumococcal
conjugate
vaccine
PRACTICES OF MENINGOCOCCAL
VACCINATION
In USA, the Advisory Committee on Immunization
Practices (ACIP) recommends routine vaccination
for all children aged 11-18 years old with 4-valent
meningococcal conjugate vaccine and children below
11 years old with high risk conditions (e.g. complement
deficiencies or travelling to endemic regions) with 4-valent
meningococcal conjugate vaccine.
The WHO recommends that in countries where
the disease occurs less frequently, meningococcal
vaccination is recommended for defined risk groups,
which include:
Children and young adults residing in closed communities
Travellers to endemic areas
SPOTlight -1
www.hkmacme.org
SPOTlight -1
Complete this
course and earn
Questions:
Q&A Self-assessment
1 CME Point
Answer these on page 19 or make an online submission at: www.hkmacme.org Please indicate whether the following statements are true or false.
1.
2.
3.
4.
Patients with Japanese encephalitis in an endemic area have an incubation period of 10-20 days.
MRI findings in Japanese encephalitis often show bilateral cerebral lesions with hemorrhage.
The new JEV vaccine available is a live-attenuated recombinant vaccine.
Protection rate is still 100% 28 days after a dose of JEV vaccine in children 12-24 months old, and
protection rate 85% 2 years afterwards.
5. Fever was reported in 50% of children after JEV vaccination.
6. Meningococcal infection always leads to predominant septicaemia and meningoencephalitis.
7. About 20% of patients surviving meningococcal disease suffers from sequelae such as hearing loss and
neurologic disability.
8. In countries where the disease occurs less frequently, meningococcal vaccination is recommended for
defined risk groups, which include children and young adults residing in closed communities, and travellers
to higher endemic areas.
9. In Mainland China, Chinese Center for Disease Control and Prevention recommends meningococcal
polysaccharide vaccine (serogroups A and B) to be included in the national childhood immunization
programme.
10. Hong Kong students going to USA for university education should usually receive Meningococcal A, C, Y,
W-135 conjugate vaccine before leaving Hong Kong.
:
:
:
:
Deadline
General Practitioners
Approximately 8-10 A-4 pages in 12-pt fonts in single line spacing, or around 1,500-2,000 words (excluding
references).
Include 10 self-assessment questions in true-or-false format.
(It is recommended that analysis and answers to most questions be covered in the article.)
English
It is preferable that key messages in each paragraph/section be highlighted in bold types.
Recommended to include, if possible, a key message in point-from at the end of the article.
List of full name(s) of author(s), with qualifications and current appointment quoted, plus a digital photograph of
each author.
All manuscripts for publication of the month should reach the Editor before the 1st of the previous month.
All articles submitted for publication are subject to review and editing by the Editorial Board.
www.hkmacme.org
SPOTlight -2
Recent advances
in cataract and
refractive surgery
Cataract surgery has gone through major leaps in the
last decades with lot of advances in both technology
and the intraocular lens design. It enables patients
to gain vision with better accuracy, and decreases
the needs on spectacles after the surgery. Refractive
surgery also undergoes simultaneous advances that
enable refractive surgery do be done in great precision
and predictability. Currently not only the refractive
error of the young, such as myopia, hyperopia and
astigmatism, but also the refractive error of the old,
presbyopia can be managed with different refractive
surgery solutions. Depending on the condition, the
two surgeries are combining together to solve multiple
problems at the same time.
SPOTlight -2
www.hkmacme.org
SPOTlight -2
www.hkmacme.org
11
SPOTlight -2
12
www.hkmacme.org
SPOTlight -2
References:
www.hkmacme.org
(19) Ali JL, Abdou AA, Puente AA, Zato MA, Nagy Z. Femtosecond
laser cataract surgery: updates on technologies and outcomes. J
Refract Surg. 2014 Jun;30(6):420-7.
(20) Jendritza BB, Knorz MC, Morton S. Wavefront-guided excimer
laser vision correction after multifocal IOL implantation. J Refract
Surg. 2008 Mar;24(3):274-9.
(21) Velarde JI, Anton PG,et al. Intraocular lens implantation and
laser in situ keratomileusis (bioptics) to correct high myopia and
hyperopia with astigmatism. J Refract Surg. 2001 Mar-Apr;17(2
Suppl):S234-7.
(22) Leccisotti A. Bioptics: where do things stand? Curr Opin
Ophthalmol. 2006 Aug;17(4):399-405.
Q&A
Self-assessment
questions:
Complete this
course and earn
1 CME Point
1.
13
Cardiology
Q&A
14
www.hkmacme.org
Cardiology
October Answers
Answer:
1) All correct
2) Torsades de pointe
3) All correct
4) Tranvenous pacing
5) Complete heart block
6) Permanent pacemaker
Figure 1
Figure 4
Figure 2
Figure 3
www.hkmacme.org
15
Dermatology
Q&A
1.
2.
3.
4.
5.
October Answers
Answers:
1. T h e d i a g n o s i s i s r o s a c e a . I t i s a c h r o n i c
inflammatory skin disorder, affecting the
cheeks, chin, nose and sometimes the
forehead, affecting more than 16 million
people in the United States. It can manifest as
different cutaneous signs such as erythema,
telangiectasias, papules, pustules, ocular lesions
(dryness, irritation, blepharitis, conjunctivitis and
keratitis) and rhinophyma. It is more prevalent in
women than in men.
16
www.hkmacme.org
Overturning Medical
Council Inquiry
Decisions Part 1
Dr. CHOI Kin
www.hkmacme.org
17
Date
Venue
Conference Rooms 1&2, 2/F., Main Building, Kowloon Hospital, 147A Argyle Street, Kowloon
Time
Welcome Remarks by Dr. CHOY Yuen Chung, President of Kowloon Hospital Alumni Society
Speech by Dr. AU Yiu Kai, Council Member of Hong Kong Medical Association
Presentation of Souvenirs
Back and Neck Pain, Localize and Manage
Dr. CHIN Ping Hong, Consultant, Spine & Rehabilitation, Department of Orthopaedics and
Traumatology, Queen Elizabeth Hospital
Interventional Management of Neck and Back Pain
Dr. Steven WONG, Consultant, Department of Anaesthesiology & Operating Theatre Services,
Queen Elizabeth Hospital
Occupational Therapy Services for Chronic Pain Adaptation
Mr. LEUNG Kwok Fai, Cluster Manager, Occupational Therapy Services, Kowloon Central
Cluster, Hospital Authority
Contemporary Physiotherapy Management in Back & Neck Pain
Mr. Kenneth LEUNG, Senior Physiotherapist, Physiotherapy Department, Kowloon Hospital
Q&A
Vote of Thanks by Dr. CHOY Yuen Chung, President of Kowloon Hospital Alumni Society
100
All medical & health professionals are welcome. Registration not required.
MCHK/HKMA CME Accreditation: pending
CNE/CPE: pending
Lunch is sponsored by
Please contact Ms. CHOW FK on 9052 5550 for enquiries.
18
www.hkmacme.org
Name
Signature
Answer Sheet
xxx(x)
November 2015
ANSWER SHEET
Please answer ALL questions and write the answers in the space provided.
SPOTlight - 1
10
10
SPOTlight - 2
Complete BOTH Cardiology & Dermatology cases and earn 0.5 CME point
Cardiology
1
2015 12 15
( 2865 0943)
Dermatology
1
www.hkmacme.org
19
CMEnotifications
HKMA CME Programme
Date:
Time:
Venue:
[ ]
Registration:
:
Please fill in and return the Registration Form together with a cheque of adequate amount made payable to The
/
Hong Kong Medical Association to 5/F Duke of Windsor Social Service Building, 15 Hennessy Road, Hong
: 2865 0943
Kong. Each lecture will carry 1 CME point under the MCHK/HKMA CME Programme (unless otherwise stated).
Accreditation from other colleges is pending. (The Secretariat fax no.: 2865 0943)
To be more eco-friendly and avoid postal delay, notification to registrants will no longer be made through
sending confirmation letters but via SMS. Please fill in your updated mobile number so that you can be notified
of your application. If you do not have a mobile phone number, the Secretariat will issue a confirmation letter to 2527 8452
you. If you have not received any replies, please do not hesitate to contact us at 2527 8452.
When Tropical Storm Warning Signal No. 8 (or above) or the Black Rainstorm Warning Signal is hoisted When Tropical Storm Warning Signal No. 8 (or above) or the Black Rainstorm Warning Signal is hoisted
within 3 hours of the commencement time, the relevant CME function will be cancelled. (i.e. CME starting after CME commencement, announcement will be made depending on the conditions as to whether the
at 2:00 pm will be cancelled if the warning signal is hoisted or in force any time between 11:00 am and CME will be terminated earlier or be conducted until the end of the session.
2:00 pm).
The above are general guidelines only. Individuals should decide on their CME attendance according to
The function will proceed as scheduled if the signal is lowered three hours before the commencement their own transportation and work/home location considerations to ensure personal safety.
time. (i.e. CME starting at 2:00 pm will proceed if the warning signal is lowered at 11:00 am, but will be
cancelled even if it is lowered at 11:01 am).
Reply Slip
Please as appropriate.
HKMA Member
HK$50
CME Participants
HK$80
HK$
Name :
HKMA Membership No. or HKMA CME No.
Mobile No. :
Fax No. :
Signature :
Date
Data collected will be used and processed for the purposes related to the MCHK/HKMA CME Programme only. All registration fees are not refundable or transferable.
20
www.hkmacme.org
CMEnotifications
Organizer
Date
Time
Venue
Moderator
Deadline
Fee
: Free-of-charge
Capacity
Enquiry
Sponsor
CME Accreditation
: Pending
REPLY SLIP
Fax: 2865 0943
Please as appropriate
Name:
Mobile No.*:
HKMA No.:
Fax No.:
*Please fill in your updated mobile number so that you can be notified of your application via SMS. If you do not have a mobile phone,
the Secretariat will still issue you a confirmation letter.
Practising location:
* Null entry will be treated as non-Kowloon West or non-New Territories West member registration.
Signature:
Date:
Data collected will be used and processed for the purposes related to these events only.
www.hkmacme.org
21
CMEnotifications
CME Lectures in December 2015
THE HONG KONG
MEDICAL ASSOCIATION
Organizer
Date
Time
Venue
Moderator
Deadline
Fee
: Free-of-charge
Capacity
: 80
48
Sponsor
CME Accreditation
: Pending
REPLY SLIP
Fax: 2865 0943
Please as appropriate
Name:
Mobile No.*:
HKMA No.:
Fax No.:
* Please fill in your updated mobile number so that you can be notified of your application via SMS. If you do not have a mobile phone,
the Secretariat will still issue you a confirmation letter.
Practising location:
)
)
* Null entry will be treated as non-Hong Kong Central, Western & Southern or non-Kowloon East member registration.
Signature:
Date:
Data collected will be used and processed for the purposes related to these events only.
22
www.hkmacme.org
CMEnotifications
Co-organized by
Date
: A Pathophysiological Approach
to the Treatment of Type 2 Diabetes
Dr. MA Pui Shan
Specialist in Endocrinology, Diabetes &
Metabolism
Time
Venue
Moderator
Deadline
Fee
: Free-of-charge
Capacity
Enquiry
Sponsor
CME Accreditation
: Pending
REPLY SLIP
Fax: 2865 0943
Please as appropriate
17 December 2015
Name:
Mobile No.*:
HKMA No.:
Fax No.:
*Please fill in your updated mobile number so that you can be notified of your application via SMS. If you do not have a mobile phone,
the Secretariat will still issue a confirmation letter to you.
Practising location:
Signature:
Date:
Data collected will be used and processed for the purposes related to these events only.
www.hkmacme.org
23
CMEnotifications
Advance in Rheumatic Diseases
Co-organized by
The HKMA Kowloon West Community Network
and Hong Kong Society of Rheumatology
Date
Speaker
Specialist in Rheumatology
Time
Venue
Moderator
Deadline
Fee
: Free-of-charge
Capacity
Enquiry
*Please call and confirm that your facsimile has been successfully transmitted to the HKMA
Secretariat if you do not receive confirmation 14 days before the event.
CME
Accreditation
: Pending
REPLY SLIP
Fax: 2865 0943
Please as appropriate
HKMA No.:
Fax No.:
Name:
Mobile No.*:
*Please fill in your updated mobile number so that you can be notified of your application via SMS. If you do not have a mobile phone,
the Secretariat will still issue a confirmation letter to you.
Practising location:
Signature:
Date:
Data collected will be used and processed for the purposes related to this event only.
24
www.hkmacme.org
CMEnotifications
Date
Speaker
Time
Venue
Moderator
Deadline
Fee
: Free-of-charge
Capacity
Enquiry
*Please call and confirm that your facsimile has been successfully transmitted to the HKMA
Secretariat if you do not receive confirmation 14 days before the event.
CME
Accreditation
: Pending
REPLY SLIP
Fax: 2865 0943
Complementary and Alternative Medicine (CAM) for Childhood Asthma: An Overview of Evidence
I would like to register for the above lecture.
Please as appropriate
HKMA No.:
Fax:
Name:
Mobile No.*:
*Please fill in your updated mobile number so that you can be notified of your application via SMS. If you do not have a mobile phone,
the Secretariat will still issue a confirmation letter to you.
Practising location:
Signature:
Date:
Data collected will be used and processed for the purposes related to this event only.
www.hkmacme.org
25
Meeting Highlights
Dr. KWAN Wing Hong, Specialist in Radiology, will give a talk on Targeted Therapy for
General Practitioners on Thursday, 10 December 2015. Interested members please refer
to the announcement on p.20 for details and enrolment.
26
www.hkmacme.org
Meeting Highlights
The HKMA Kowloon East Community Network (KECN) ~ Dr. AU Ka Kui, Gary
Dr. CHAN Chun Chung, Specialist in Geriatric Medicine, gave a talk on Update on
Type 2 Diabetes Management in Elderly on Thursday, 8 October 2015. The final
session of the CME Course for Health Personnel 2015 titled Common Shoulder
and Upper Limb Problems was given by Dr. LUK Man Sze, Karen, Associate
Consultant of Department of Orthopaedics & Traumatology of United Christian
Hospital, on Saturday, 17 October 2015. Dr. CHAN Chi Kin, Hamish, Specialist in
Cardiology, delivered a lecture on Cardiac Arrhythmia Update on Thursday, 22
October 2015.
A CME lecture on Shingles Prevention from
Infectious Disease Specialists Perspective will be
presented by Dr. SO Man Kit, Thomas, Specialist
in Infectious Disease, on Thursday, 10 December
2015. Interested members please refer to the
announcement on p.22 for details and enrolment.
The HKMA Hong Kong East Community Network (HKECN) ~ Dr. CHAN Nim Tak, Douglas
The talk on Update on Diagnosis and Management of Psoriatic Arthritis was delivered by Dr. CHAN Pak To, Specialist in
Rheumatology, on Thursday, 8 October 2015. Moreover, the lecture on The Evolving Treatment Paradigm of Type 2 Diabetes
was given by Dr. CHAN Wing Bun, Specialist in Endocrinology, Diabetes & Metabolism, on Thursday, 22 October 2015.
Dr. MA Pui Shan, Specialist in Endocrinology,
Diabetes & Metabolism, will present on A
Pathophysiological Approach to the Treatment
of Type 2 Diabetes on Thursday, 3 December
2015. Dr. CHAN Hoi Yee, Catherine, Specialist
in Ophthalmology, will deliver a lecture on
Recent Development in DME Management
on Thursday, 17 December 2015. Interested
members please refer to the announcement on
p.23 for details and enrolment.
Dr. CHAH Pak To (left, speaker) receiving a
souvenir from Dr. Silas NGAN (moderator)
during the lecture on 8 October 2015
www.hkmacme.org
27
Meeting Highlights
The HKMA Kowloon West Community Network (KWCN) ~ Dr. TONG Kai Sing
Dr. HSU Yau Que, Specialist in Internal Medicine, presented on Update on Non-Alcoholic Fatty Liver Disease (NAFLD) on
Tuesday, 6 October 2015. Dr. CHAN Kam Tim, Michael, Specialist in Dermatology & Venereology, gave a talk on Treatment
and Prevention of Eczema Flares by Combination Therapy (Latest AAD Guideline Update) on Tuesday, 20 October 2015.
Dr. TSUI Hing Sum, Kenneth, Specialist in Rheumatology, will deliver a lecture on Advance in Rheumatic Diseases which is
co-organized by the Network and Hong Kong Society of Rheumatology on Tuesday, 1 December 2015. Interested members
please refer to the announcement on p.24 for details and enrolment.
Dr. LEE Tze Yuen, Specialist in Dermatology & Venereology, will present on Rosacea and Related Dermatoses on Tuesday,
15 December 2015. Interested members please refer to the announcement on p.21 for details and enrolment.
28
www.hkmacme.org
CMECalendar
November 2015
17 Nov 2015
(Tue)
1:00 2:00 pm
17 Nov 2015
(Tue)
1:00 3:00 pm
17 Nov 2015
(Tue)
1:00 3:00 pm
18 Nov 2015
Hong Kong Medical Association and the Chinese Medical Association
(Wed)
17th Beijing/Hong Kong Medical Exchange: Recent Advances in
9:00 05:00 pm Orthopaedics
Chongqing Yuelai Wyndham Hotel
HKMA CME Dept. Tel: 2527 8452
19 Nov 2015
(Thu)
1:00 3:00 pm
19 Nov 2015
(Thu)
1:00 3:00 pm
19 Nov 2015
(Thu)
1:00 3:00 pm
19 Nov 2015
(Thu)
2:00 3:00 pm
21 Nov 2015
(Sat)
1:30 4:00 pm
24 Nov 2015
(Tue)
6:30 9:30 pm
25 Nov 2015
(Wed)
1:00 2:00 pm
25 Nov 2015
(Wed)
1:00 3:00 pm
26 Nov 2015
Hong Kong Sanatorium & Hospital Orthopaedic & Sports Medicine
(Thu)
Centre
8:30 10:30 am Academic Professional Development Meeting 2015 of OSMC HKSH (Every
Fourth Thursday of the Month)
Hong Kong Sanatorium & Hospital
Ms. Cheng Hoi Yan Tel: 2835 7890
www.hkmacme.org
26 Nov 2015
(Thu)
1:00 3:00 pm
26 Nov 2015
(Thu)
1:00 3:00 pm
26 Nov 2015
(Thu)
1:00 3:00 pm
27 Nov 2015
(Fri)
1:00 3:00 pm
28 Nov 2015
Hospital Authority
(Sat)
Hong Kong College of Community Medicine
9:30 11:30 am Case presentations and Journal presentations in areas related to
Administrative Medicine
Room 524N, 5/F, Hospital Authority Building, 147B Argyle Street, Kowloon
Ms. Yandy Ho Tel: 2871 8745
28 Nov 2015
(Sat)
2:30 4:30 pm
1 Dec 2015
(Tue)
1:00 3:00 pm
2 Dec 2015
(Wed)
1:00 3:00 pm
3 Dec 2015
(Thu)
1:00 3:00 pm
8 Dec 2015
(Tue)
1:00 3:00 pm
9 Dec 2015
(Wed)
5:00 7:00 pm
10 Dec 2015
(Thu)
1:00 3:00 pm
10 Dec 2015
(Thu)
1:15 3:00 pm
2.5
11 Dec 2015
(Fri)
1:00 2:00 pm
12 Dec 2015
(Sat)
2:15 4:15 pm
29